Raltitrexed in Treating Children With Refractory Acute Leukemia

Clinical trial NCT00003528 · COMPLETED

Trial details

NCT number: NCT00003528
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia

Start date: 1998-09-01
Primary completion: 2002-06-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.